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Background: Mortality from colorectal cancer (CRC) can be reduced drastically by early detection and early treatment. However, uptake 
of CRC screening is relatively low, about 50% for those whom the test is highly recommended.
Objectives: We examined the influence of and racial differences in depression, insomnia, alcohol use, and tobacco use on CRC screening 
uptake in the US.
Patients and Methods: Analysis of the 2012 National Health Information Survey data was conducted. Both weighted univariate and 
multiple logistic regression analyses were performed in SAS to estimate the odds ratios (ORs) and their 95% confidence intervals (CIs). A 
total of 21511 participants were included in the analysis.
Results: Prevalence of CRC screening in the participants was 19%. Adjusting for all factors, insomnia (OR = 1.18, 95%CI = 1.06 - 1.32), moderate 
alcohol drinking (OR = 1.16, 95%CI = 1.01 - 1.30), past smoking (OR = 1.17, 95%CI = 1.04 - 1.32), depression (OR = 1.37, 95%CI = 1.18 - 1.58), African 
American (AA) race, and cancer history were positively associated with CRC screening. Females and Single were inversely associated with 
CRC screening prevalence. In stratified analysis by races (White and AA), depression was associated with CRC screening in both races. 
Marital status, smoking, cancer history and insomnia were associated with CRC screening in Whites only; while alcohol use was associated 
with CRC screening in AAs only.
Conclusions: We have found significant associations between lifestyle factors (alcohol consumption and smoking) and mental health 
problems (depression and insomnia) and CRC screening uptake. To improve overall CRC screening uptake in the US, it is important to 
consider racial differences in predictors and tailor appropriate interventions to each racial/ethnic group.
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1. Background
Colorectal cancer (CRC) remains the second leading 
cause of cancer deaths in the United States (US) (1), de-
spite the high survival rate from early treatment (2). It is 
estimated that 136830 new cases of colorectal cancer will 
be recorded in 2014 in the US and 50310 of these cases will 
die from the disease (3). Cancer of the colon and rectum 
affects both males and females equally, and the risk in-
creases with age (3, 4). Mortality from CRC can be reduced 
drastically by early detection and early treatment. The sur-
vival rate for colorectal cancer is very low at late diagno-
sis of the disease. Five-year survival rates as high as about 
90% have been reported for tumors detected and removed 
before extension (2). Evidence also indicates a reduction 
in the survival rate to about 70% for tumors which have 
already extended, and as low as 13% when metastasis has 
already occurred (2). Decline in CRC mortality rates in the 
US has been attributed to early detection and surgical re-
moval of the tumor before metastasis (5). Early detection 
and early treatment are possible due to the availability of 
effective and relatively inexpensive CRC screening tests (6). 
A clinical trial showed 33 and 43% reductions in incidence 
and mortality of CRC respectively as result of a single sig-
moidoscopy screening of adults between 55 and 64 years 
(7). In the US, CRC screening is covered by most health 
plans and there is a published guideline for CRC screen-
ing (8). However, uptake of CRC screening is relatively low, 
and it is about 50% of those for whom the test is highly 
recommended (9-11). This calls for public health efforts to 
increase awareness, acceptance and uptake of CRC screen-
ing, especially for those with increased risk. Researching 
factors that promote CRC screening is therefore crucial for 
public health interventions. Reported predictors of CRC 
screening include age, educational level, income level, and 
health insurance status (9, 12). These predictors are similar 
to predictors for other screening programs, such as mam-
mography. It therefore raises questions about the low up-
take of CRC compared to screening programs for other 
cancers. This calls for more investigation into predictors 
of CRC screening uptake to inform policy and interven-
tion planning. Several studies exist on the relationship 
between mental health and attitudes towards health pro-
grams. The link between depression, alcohol and tobacco 
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use; and screening uptake have also been investigated. 
However, studies have differed on their findings. A study 
investigated the influence of depression on other cancer 
screening among breast cancer survivors in Latino. An in-
verse association was observed between depression and 
CRC screening uptake (13). A recent survey in Washington 
State in the US identified depression as a significant bar-
rier to cervical cancer screening uptake (14). This finding 
partly corroborated a previous observation made in Can-
ada (15). However, Kaida and co-workers (15) observed that 
age played an important role in the relationship between 
depression and cervical cancer screening. In contrast, Kodl 
and co-workers observed a significant increase in CRC up-
take among those with mental health diagnosis in a bi-
variate analysis (16). However, inverse association was ob-
served when they controlled for timing of diagnosis and 
outpatient visits. This observation suggests that depres-
sion affects screening indirectly. In the United Kingdom, 
it was observed that lower depression indirectly increases 
uptake of CRC screening through a better self-rated health 
(17). These findings call for more investigation into the re-
lationship between mental health and CRC screening to 
inform policy and intervention. Insomnia has been found 
to be common among cancer patients (18). However, to the 
best of our knowledge, the relationship between insom-
nia and CRC screening uptake has not yet been evaluated. 
Again, racial differences in the influence of depression on 
CRC screening have not yet been evaluated.
2. Objectives
We examined the influence of and racial differences in 
depression, insomnia, alcohol use, and tobacco use on 
CRC screening uptake in the USA.
3. Patients and Methods
3.1. Data Source
The National Health Interview Survey (NHIS) is a multi-
purpose health survey which is conducted by the Nation-
al Center for Health Statistics (NCHS), Center for Disease 
Control and Prevention (CDC). It is a principal source of 
health information of the civilian noninstitutionalized 
household population of the US. The NHIS has been con-
ducted continually since it began in 1957. Public-use data 
files are released annually and can be accessed from the 
internet. From each family in the NHIS, one adult aged 18 
years or older is randomly selected to respond to sample 
adult core questionnaires. Details of the methods of this 
survey have been published elsewhere (19). The 2012 NHIS 
sample is the largest sample size since the current sam-
pling strategy came into force in 2006. Analysis of 2012 
data from the National Health Information survey (NHIS) 
was done to determine associations between depression, 
insomnia, alcohol use and tobacco use, and colorectal 
cancer screening in participants.
Table 1.  Subjects Characteristics of the 2012 National Health 
Interview Survey a,b,c




Male 2026 (54) 7516 (46)
Female 2014 (46) 9955 (54)
Age group, y
18 - 44 182 (6) 2609 (16)
45 - 64 2194 (59) 9340 (57)
≥ 65 1664 (36) 5522 (27)
Race
White 2819 (79) 13015 (80)
AA 800 (13) 2469 (10)
Asian 129 (3 547 (3)
Other 292 (5) 1440 (7)
Marital status
Married 2205 (70) 8916 (66)
Divorced 1447 (24) 6401 (25)
Single 385 (6) 2105 (9)
Income, USD
0 - 34999 1431 (26) 7012 (32)
35000 - 74999 1198 (33) 4944 (32)
≥ 75000 1141 (41) 4379 (36)
Cancer his-
tory
No 3285 (82) 15406 (88)
Yes 753 (18) 2054 (12)
Alcohol use
Never 776 (18) 3897 (21)
Past 888 (21) 3455 (20)
Moderate 2151 (61) 9055 (50)
Smoking 
status
Never 2063 (51) 9609 (56)
Current 623 (14) 3135 (17)
Past 1348 (35) 4695 (27)
Depress
No 3244 (87) 14609 (89)
Yes 570 (13) 2082 (11)
Insomnia
No 3021 (76) 13556 (79)
Yes 1018 (24) 3912 (21)
a  Abbreviations: AA, African American.
b  Data Source: CDC/NCHS, National Health Interview Survey, 2012.
c  Data are presented as No. (%).
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3.2. Measurements
Information on depression, insomnia, alcohol use and 
tobacco use was self-reported. Participants were con-
sidered to have had a CRC screening (case) if they re-
sponded “yes” to the question “Test for colon cancer, past 
12 months” (Table 1). Subjects who answered “no” to the 
question served as controls. Demographic variables col-
lected and used in this analysis included age, classified as 
young (18 - 44 years), middle aged (45 - 64 years), and el-
derly (65 years or older); gender; race/ethnicity (White, Af-
rican American (AA), Asian and other). Marital status was 
classified into married/living with partner; widowed/di-
vorced/separated; and Single. Insomnia was determined 
by the question “Insomnia, past 12 months” (yes. no). 
Depression case was recorded from “yes” answer to the 
question “Ever had depression, past 12 months” (yes/no). 
Smoking status was classified as never smoked, current 
smoking, or past smoking. Alcohol consumption was 
classified as never, current light or moderate drinking, 
and past drinking. Income level was categorized into low 
income (0 - 34999 USD), middle income (35000 - 74999 
USD) and high income (≥ 75000 USD).
3.3. Statistical Analysis
Population proportions in cases and controls of in-
dependent variables and demographic factors were es-
timated by PROC SURVEYFREQ procedure in SAS. PROC 
SURVEYMEANS procedure was also used to estimate the 
overall prevalence of CRC screening; while SAS PROC SUR-
VEYFREQ was used to estimate the prevalence in poten-
tial factors. Chi-square test was used to compare preva-
lence of CRC screening across groups. Odds ratios (ORs) 
and their 95% confidence intervals (CIs) were estimated 
for each of the suspected predictors of CRC screening by 
PRC SURVEYLOGISTIC procedure. A multiple logistic re-
gression was performed for all races combined and then 
stratified by race (white and AA). All the analyses were 
conducted with SAS statistical software, version 9.2 (SAS 
Institute, Cary, NC, USA).
4. Results
4.1. Subjects Characteristics and Prevalence
There were 21511 participants included in the analysis, 
comprising 9542 (44%) males and 11966 (56%) females. 
Table 1 shows detailed characteristics of the study par-
ticipants. A higher percentage of males reported hav-
ing CRC screening in the last 12 months (54% vs. 46%). 
Proportion of older adults was higher in cases than 
in controls (36% vs. 27%). African-American (AA) adults 
and married also formed higher proportions in cases 
than in controls (13% vs. 10%, 70% vs. 66%, respectively). 
A higher proportion of cases had higher income than 
controls (41% vs. 36%). Table 2 illustrates the prevalence 
of CRC screening by demographic factors and other 
independent variables. The overall prevalence of CRC 
screening in the sample was 19%. The prevalence of 
CRC screening in adults with cancer, depression and 
insomnia was significantly higher than those without 
the conditions (26% vs.18%; 21% vs.18%; and 21% vs.18%, re-
spectively). Prevalence of CRC screening was highest in 
past smokers compared to current smokers and never 
smokers (23% vs. 16% vs. 18%). Participants with past alco-
hol use recorded the highest prevalence of CRC screen-
ing compared to current and never alcohol users (20% 
vs.19% vs. 16%).
4.2. The Relationship Between all Potential Risk 
Factors and CRC Screening in all Races
Results of both univariate and multiple logistic regres-
sion analyses of the association between CRC screening 
and all factors included in the model are shown in Table 3. 
There were significant associations between CRC screen-
ing and all factors examined in the unadjusted analysis 
(P < 0.05). Adjusting for all other factors, cancer history 
(OR = 1.51, 95%CI = 1.32 - 1.73); moderate alcohol drinking 
(OR = 1.16, 95%CI = 1.01 - 1.30); past smoking (OR = 1.17, 95%CI 
= 1.04 - 1.32); depression (OR = 1.37, 95%CI = 1.18 - 1.58); AA 
race (OR = 1.74, 95% CI = 1.53 - 1.98) and insomnia (OR = 1.18, 
95%CI = 1.06 - 1.32) were all positively associated with CRC 
screening. Females (OR = 0.73; 95% CI = 0.66 - 0.82) and 
Single (OR = 0.78, 95% CI = 0.66 - 0.91) were inversely as-
sociated with CRC screening prevalence. Compared to 
young adults (18 - 44 years), screening was significantly 
higher in middle-aged and the older adults (≥ 65) (OR = 
2.91, 95%CI = 2.35 - 3.62 and OR = 3.76, 95%CI = 2.99 - 4.74, 
respectively). Compared to low income earners (0 - 34999 
USD), CRC screening was significantly higher in middle 
income (35000 - 74999 USD) and high income (≥ 75000) 
earners (OR = 1.32, 95% CI = 1.17 - 1.48; and OR = 1.50, 95% CI 
= 1.31 - 1.73, respectively).
4.3. Relationship Between CRC Screening and 
all Factors Stratified by Race (White and African 
American)
 Table 4 provides detailed results of multiple logistic re-
gression analysis, stratified by race. Adjusting for all other 
factors, age, income and depression showed significant 
positive association with CRC screening in both Whites 
and AAs. In both races, females were less likely to screen 
for CRC. While the single were significantly less likely to 
receive CRC screening among Whites (OR = 0.75, 95%CI = 
0.61 - 0.92), marital status was not significantly associated 
with CRC screening among AA (P > 0.4). Cancer history 
was positively associated with CRC screening in Whites 
(OR = 1.55, 95%CI = 1.33 - 1.79) but not significant in AAs (P 
> 0.1). There was a 47% significant increase in CRC screen-
ing in past alcohol users among AAs (95% CI = 1.06 - 2.09) 
but alcohol use was not associated with CRC screening in 
Whites (P > 0.1). In both races, CRC screening was slightly 
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but not significantly reduced in current smokers, how-
ever, past smoking was positively associated with CRC 
screening in Whites (OR = 1.29, 95% CI = 1.09 - 1.53) but not 
in AAs. History of insomnia also increased CRC screening 
in Whites (OR = 1.17, 95% CI = 1.03 - 1.34) but it was not sig-
nificantly associated with CRC screening in AAs.
Table 2.  CRC Prevalence of Demographic Characteristics (%) a,b,c
Variable Total, N Cases, N Prevalence, % 95%CI P Value
Gender < 0.0001
Male 9542 2026 21.2 20.2 - 22.3
Female 11969 2014 16.5 15.62 - 17.4
Age group, y < 0.0001
18 - 44 2791 182 7.4 6.1 - 8.8
45 - 64 11534 2194 19.4 18.5 - 20.4
≥ 65 7186 1664 23.0 21.9 - 24.2
Race < 0.0001
White 15834 2819 18.4 17.7 - 19.2
AA 5269 800 23.6 21.8 - 25.3
Asian 676 129 17.9 14.5 - 21.3
Other 1732 292 14.9 12.9 - 17.0
Marital status < 0.0001
Married 9542 2205 19.7 18.2 - 22.3
Divorced 11969 1447 18.2 15.6 - 17.4
Single 11969 385 13.4 11.9 - 14.9
Income, USD < 0.0001
0 - 34999 8443 1431 15.9 15.0 - 16.9
35000 - 74999 6142 1198 19.5 18.3 - 20.6
≥ 75000 5520 1141 20.7 19.4 - 22.1
Cancer history < 0.0001
No 18691 3285 17.6 16.9 - 18.3
Yes 2807 753 26.4 24.4 - 28.4
Alcohol use
Never 4673 776 16.3 14.8 - 17.7 0.0009
Past 4343 888 20.3 18.6 - 21.8
Moderate 11206 5151 19.3 18.3 - 20.3
Smoking status < 0.0001
Never 11672 2063 17.6 16.6 - 18.5
Current 3758 623 15.7 14.3 - 17.2
Past 6043 1348 22.8 21.4 - 24.1
Depression 0.0019
No 17853 3244 18.3 17.6 - 18.9
Yes 2652 570 21.4 19.4 - 23.4
Insomnia 0.0001
No 16577 3021 18.1 17.4 - 18.9
Yes 4930 1018 20.9 19.6 - 22.3
Overall 21511 4040 18.8 18.1 - 19.4
a  Abbreviations: AA, African American.
b  P value is based on χ2 test.
c  Data Source: CDC/NCHS, National Health Interview Survey, 2012.
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Table 3.  Univariate and Multiple Logistic Regression Analyses for the Relationship Between Potential Factors and CRC Screening a,b
Variable Crude OR 95%CI P Value Adjusted OR 95%CI P Value
Gender
Male 1 1
Female 0.73 0.66 - 0.81 < 0.0001 0.73 0.66 - 0.82 < 0.0001
Age group, y
18 - 44 1 1
45 - 64 2.99 2.42 - 3.70 < 0.0001 2.91 2.35 - 3.62 < 0.0001
≥ 65 3.71 2.98 - 4.63 < 0.0001 3.76 2.99 - 4.74 < 0.0001
Race
White 1 1
AA 1.35 1.21 - 1.52 < 0.0001 1.74 1.53 - 1.98 < 0.0001
Asian 0.90 0.69 - 1.16 0.406 1.05 0.80 - 1.37 0.732
Other 0.80 0.67 - 0.95 0.01 1.07 0.89 - 1.28 0.489
Marital status
Married 1 1
Divorced 0.91 0.83 - 0.99 0.0456 0.91 0.82 - 1.02 0.114
Single 0.67 0.58 - 0.78 < 0.0001 0.78 0.66 - 0.91 0.002
Income, USD
0 - 34999 1 1
35000 - 74999 1.28 1.15 - 1.42 < 0.0001 1.32 1.17 - 1.48 < 0.0001
≥ 75000 1.34 1.19 - 1.50 < 0.0001 1.50 1.31 - 1.73 < 0.0001
Cancer history
No 1 1
Yes 1.71 1.52 - 1.94 < 0.0001 1.51 1.32 - 1.73 < 0.0001
Alcohol use
Never 1 1
Past 1.34 1.14 - 1.58 0.0004 1.14 0.96 - 1.36 0.142
Moderate 1.25 1.11 - 1.42 0.0004 1.16 1.01 - 1.34 0.0361
Smoking status
Never 1 1
Current 0.90 0.78 - 1.03 0.112 0.90 0.78 - 1.05 0.176
Past 1.40 1.26 - 1.56 < 0.0001 1.17 1.04 - 1.32 0.0119
Depress
No 1 1
Yes 1.23 1.08 - 1.40 0.0025 1.37 1.18 - 1.58 < 0.0001
Insomnia
No 1 1
Yes 1.18 1.07 - 1.31 0.0014 1.18 1.06 - 1.32 0.0041
a  Abbreviations: AA, African American; OR, Odds ratio; CI, Confidence interval.
b  Data Source: CDC/NCHS, National Health Interview Survey, 2012.
5. Discussion
In the combined analysis, increasing age, high in-
come, being male, depression, insomnia, past smok-
ing, moderate alcohol drinking, and AA race were all 
associated with increased CRC screening. CRC screen-
ing prevalence was significantly reduced in the Single 
compared to the married or living with partner. In a 
stratified analysis by race groups, significant differenc-
es in CRC screening predictors were observed between 
Whites and AAs. There was a significant increase in CRC 
screening with increasing age, increasing income level, 
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and depression in both races. Similar to the combined 
analysis, females were less likely to screen for CRC in 
both Whites and AAs. Cancer history, marital status, 
and insomnia were associated with CRC screening in 
Whites but not in AAs. Past alcohol drinking increased 
screening in AAs but alcohol was not associated with 
screening in Whites. The relationship between age, gen-
der, income level and CRC screening have been widely 
reported in the literature, and our findings are in line 
with those already reported (9, 12). However, in con-
trast with findings in the literature (9, 12), our analysis 
found a significant increase in CRC screening among 
AAs compared to Whites. This increase may stem from 
perception of risk. Though our analysis cannot fully ex-
plain why CRC screening is higher in AAs than Whites, 
it is important to note that incidence of and mortality 
from CRC have been reported to be higher in AAs than 
all other racial/ethnic groups in the USA (20-24). Aware-
ness of this statistics can trigger uptake of screening as 
has been shown previously (25).
Table 4.  Multiple Logistic Regression Analysis for the Relationship between Potential Factors and CRC Screening by Race Status a,b
Variable Adjusted OR (White) 95%CI P Value Adjusted OR (AA) 95%CI P Value
Gender
Male 1 1
Female 0.71 0.62 - 0.80 < 0.0001 0.77 0.61 - 0.97 0.0251
Age group, y
18 - 44 1 1
45 - 64 2.66 2.08 - 3.98 < 0.0001 3.62 2.15 - 6.09 < 0.0001
≥ 65 3.20 2.47 - 4.14 < 0.0001 4.96 2.84 - 8.64 < 0.0001
Marital status
Married 1 1
Divorced 0.89 0.78 - 1.02 0.0953 1.10 0.87 - 1.41 0.429
Single 0.75 0.61 - 0.92 0.0067 0.93 0.68 - 1.26 0.630
Income, USD
0 - 34999 1 1
35000 - 74999 1.32 1.14 - 1.51 0.0001 1.46 1.15 - 1.86 0.0021
≥ 75000 1.47 1.25 - 1.73 < 0.0001 1.53 1.10 - 2.13 0.0112
Cancer history
No 1 1
Yes 1.55 1.33 - 1.79 < 0.0001 1.29 0.91 - 1.84 0.157
Alcohol use
Never 1 1
Past 1.03 0.83 - 1.28 0.772 1.49 1.06 - 2.09 0.0218
Moderate 1.13 0.95 - 1.34 0.157 1.19 0.86 - 1.65 0.301
Smoking status
Never 1 1
Current 0.94 0.79 - 1.11 0.470 0.79 0.58 - 1.08 0.146
Past 1.17 1.02 - 1.34 0.0302 1.23 0.91 - 1.65 0.178
Depress
No 1 1
Yes 1.29 1.09 - 1.53 0.0027 1.81 1.27 - 2.57 0.001
Insomnia
No 1 1
Yes 1.17 1.03 - 1.34 0.0185 0.93 0.69 - 1.24 0.620
a  Abbreviations: AA, African American; OR, Odds ratio; CI, Confidence interval.
b  Data Source: CDC/NCHS, National Health Interview Survey, 2012.
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 The observation that moderate alcohol drinking was 
associated with increase CRC screening is similar to 
previously reported influence of alcohol consumption 
on mammography (26). However, our results indicate 
that the relationship between moderate alcohol 
drinking and cancer screening may be race-dependent. 
When stratified by race, the observed 16% increase in CRC 
screening in moderate alcohol consumption completely 
attenuated. It resulted in 47% significant increase in CRC 
screening among past alcohol users but only in AAs. 
More studies are needed to explain the racial difference. 
We have found no significant difference in CRC screening 
between current and never smokers in contrast to earlier 
finding that smoking reduces cancer screening (27, 28). 
In line with a previous report (10), we found past smoking 
to increase CRC screening in the combine analysis. Our 
stratified analysis indicated that past smoking increased 
screening in Whites only. Motivation to cease smoking 
may increase positive health behavior among past 
smokers. It suggests that campaigns to increase smoking 
cessation may also lead to improvement in healthy 
behaviors. Our findings on depression contrast most of 
the evidence reported earlier (13-15, 29). However, our 
analysis did not account for hospital visits. Number of 
outpatient visits has been found to mediate mental illness 
and health behavior (16). We are unable to attribute the 
observed influence of depression to physician visit based 
on our data, however, it is more plausible for depressed 
individuals to have increased contact with care providers 
(16) and the result may reflect the importance of health 
care provider contacts and screening uptake. This may 
also apply to those who reported symptoms of insomnia 
in the last 12 months. Increased contact with health 
care providers may increase uptake of health screening. 
Insomnia may affect up to 50% of patients with cancer and 
increases cancer symptom burden and impairs quality of 
life (18, 30-33). However, to the best of our knowledge, this 
study is the first to examine the relationship between 
insomnia and CRC screening uptake. We found that 
insomnia was positively associated with CRC screening 
and the associations showed race difference. Of 
significant important is the observed variation between 
Whites and AAs on the predictors examined. Though our 
data is limited to explain these differences, it suggests 
that race specific interventions may be important in 
improving uptake of CRC screening. However, further 
studies on these variations may be important to explain 
the difference. Our study is statistically powerful due to 
the large sample size. The use of probability sampling 
technique makes our sample representative of the 
population. Since information from participants was 
self-reported, our study may suffer from a recall bias 
as well as social desirability bias. However, recall bias 
is likely to be minimal since information collected was 
within one year. In conclusion, cancer history, smoking 
status, insomnia and alcohol intake status may influence 
CRC screening uptake differently between Whites and 
AAs. To improve overall CRC screening uptake in the US, it 
is important to consider racial differences in predictors 
and tailor appropriate interventions to each racial/
ethnic group.
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